Smoltek publishes information document in connection with the rights issue

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, AUSTRALIA, BELARUS, HONG KONG, JAPAN, CANADA, NEW ZEALAND, RUSSIA, SWITZERLAND, SINGAPORE, SOUTH AFRICA, SOUTH KOREA, OR IN ANY OTHER JURISDICTION WHERE DISTRIBUTION OF THIS PRESS RELEASE WOULD BE UNLAWFUL OR REQUIRE MEASURES OTHER THAN THOSE PROVIDED UNDER SWEDISH LAW.

Smoltek Nanotech Holding AB (publ) ("Smoltek" or the "Company") has prepared an information document (the "Information Document") in connection with the Company’s upcoming share issue with preferential rights for existing shareholders, which was resolved by the Board of Directors on May 27, 2025, based on the authorization granted by the Annual General Meeting (the "Rights Issue"). The Information Document is now available on the Company’s website www.smoltek.com/investors/en and will also be made available on Spotlight Stock Market’s website www.spotlightstockmarket.com.

On May 27, 2025, the Board of Directors of Smoltek, based on the authorization granted by the Annual General Meeting on May 14, 2025, resolved to carry out the Rights Issue of up to SEK 32.0 million. Complete information, terms, and instructions regarding the Rights Issue can be found in the Information Document. The Information Document is available on the Company’s website, www.smoltek.com/investors/en, and will also be made available on Spotlight Stock Market’s website, www.spotlightstockmarket.com.

The Information Document 
In connection with the Rights Issue, the Company has prepared an Information Document in accordance with Article 1.4 db) of Regulation (EU) 2017/1129 of the European Parliament and of the Council (the “Prospectus Regulation”). The Information Document has been prepared in accordance with the requirements set out in Annex IX of the Prospectus Regulation. The Information Document has been filed with the Swedish Financial Supervisory Authority (Finansinspektionen); however, Finansinspektionen has neither reviewed nor approved the Information Document.

Preliminary Timetable for the Rights Issue

• June 9–24, 2025: Subscription period in the Rights Issue
• June 9–18, 2025: Trading in subscription rights (TR) on Spotlight Stock Market
• June 24, 2025: Preliminary outcome of the Rights Issue is published
• June 26, 2025: Final outcome of the Rights Issue is published
• Week 27–week 28, 2025: Trading in paid subscribed shares (BTA) on Spotlight Stock Market (provided that the minimum subscription level in the Rights Issue is reached)

Advisors 
Corpura Fondkommission AB is the financial advisor in connection with the Rights Issue. MAQS Advokatbyrå AB is the legal advisor to the Company in connection with the Rights Issue.

For further information  
Magnus Andersson, CEO Smoltek Nanotech Holding AB  
E-mail: magnus.andersson@smoltek.com    
Phone: +4631 701 03 05 
Website: www.smoltek.com/investors/en  

About Smoltek 
Smoltek develops new products with disruptive performance, based on nanotechnology, that solve advanced material technology problems in several industrial sectors and is currently active in two business areas: semiconductors and hydrogen. The company protects its unique carbon nanotechnology through an extensive patent portfolio consisting of more than 110 applied for patents, of which 96 are currently granted. Smoltek's share is listed on the Spotlight Stock Market under the ticker SMOL. Smoltek is a development company and forward-looking statements regarding time to market, production volume and price levels should be interpreted as forecasts and not commitments.

Important Information 
The publication, disclosure or distribution of this press release may be subject to restrictions by law in certain jurisdictions. Recipients of this press release in jurisdictions where this press release is published or distributed should inform themselves of and comply with such legal restrictions. Recipients of this press release are responsible for using this press release and the information contained herein in accordance with the applicable laws of their respective jurisdictions. This press release does not constitute an offer to acquire or subscribe for shares or other securities issued by the Company, whether from the Company or from anyone else, in any jurisdiction where such offer or invitation would be contrary to applicable laws or would require additional registration or other measures.

This press release is not a prospectus within the meaning of Regulation (EU) 2017/1129 (the “Prospectus Regulation”) and has not been approved by any regulatory authority in any jurisdiction. No prospectus has been or will be prepared in connection with the Rights Issue. In each EEA Member State, this announcement is addressed only to "qualified investors" in that Member State as defined in the Prospectus Regulation.

This press release does not constitute an offer or solicitation of an offer to purchase or subscribe for securities in the United States. The securities referred to herein may not be sold in the United States absent registration, or the application of an exemption from registration, under the U.S. Securities Act of 1933, as amended from time to time (the “Securities Act”), and may not be offered or sold in the United States absent registration, an exemption from, or in a transaction not subject to, the registration requirements of the Securities Act. There is no intention to register any securities referred to herein in the United States or to make a public offering of such securities in the United States. The information in this press release may not be released, published, copied, reproduced or distributed, directly or indirectly, in whole or in part, in or into the United States, Australia, Belarus, Hong Kong, Japan, Canada, New Zealand, Russia, Switzerland, Singapore, South Africa, South Korea or any other jurisdiction where such release, publication or distribution of this information would be in violation of applicable regulations or where such action would be subject to legal restrictions or would require additional registration or other measures than those required by Swedish law. Actions in violation of this instruction may constitute a violation of applicable securities laws.

In the United Kingdom, this document, and other materials relating to the securities referred to herein, are being distributed and directed only to, and any investment or investment activity relating to this document is only available to and will only be available to, “qualified investors” who are (i) persons who have professional experience in investment-related activities and who fall within the definition of “professional investors” in Article 19(5) of the Financial Services and Markets Act 2000 (Financial Promotion) Order 2005 (the “Order”); or (ii) high net worth persons as referred to in Article 49(2)(a)-(d) of the Order (all such persons are collectively referred to as “relevant persons”). Any investment or investment activity to which this announcement relates is only available in the United Kingdom to relevant persons and will only be undertaken with relevant persons. Persons who are not relevant persons should not take any action based on, or act or rely on, this press release.

This press release neither identifies nor purports to identify risks (direct or indirect) that may be associated with an investment in new shares. The information in this press release is only intended to describe the background to the Rights Issue and does not claim to be complete or exhaustive. No representation is made as to the accuracy or completeness of the information in this press release. An investment decision to acquire or subscribe for shares in connection with the Rights Issue may only be made based on publicly available information regarding the Company and the Company's shares.

Failure to follow these instructions may constitute a violation of the Securities Act or applicable laws in other jurisdictions.

Forward-looking statements 
This press release contains forward-looking statements that relate to the Company's intentions, assessments or expectations regarding the Company's future results, financial position, liquidity, development, prospects, expected growth, strategies and opportunities and the markets in which the Company operates. Forward-looking statements are statements that do not relate to historical facts and can be identified by their inclusion of expressions such as "believes", "expects", "anticipates", "intends", "estimates", "will", "may", "assumes", "should", "could" and, in each case, the negations thereof, or similar expressions. The forward-looking statements in this press release are based on various assumptions, which in many cases are based on additional assumptions. Although the Company believes that the assumptions reflected in these forward-looking statements are reasonable, there can be no assurance that they will occur or that they are correct. Because these assumptions are based on assumptions or estimates and are subject to risks and uncertainties, actual results or outcomes may, for a variety of reasons, differ materially from those expressed in the forward-looking statements. Such risks, uncertainties, contingencies and other important factors could cause actual events to differ materially from the expectations expressed or implied in this press release through the forward-looking statements. The Company does not warrant that the assumptions underlying the forward-looking statements in this press release are correct and any reader of the press release should not place undue reliance on the forward-looking statements in this press release. The information, beliefs and forward-looking statements expressed or implied herein speak only as of the date of this press release and are subject to change. Neither the Company nor anyone else undertakes to review, update, confirm or publicly announce any revision to any forward-looking statement to reflect events that occur or circumstances that arise with respect to the contents of this press release, unless required by law or Spotlight's rules for issuers.

Läs mer på Cision